Q4 2024 Rubicon Organics Inc Earnings Call Transcript
Key Points
- Rubicon Organics Inc (ROMJF) achieved record high net revenue for both the 3- and 12-month periods ending December 31, 2024, with increases of 21% and 42% respectively compared to 2023.
- The company reported positive adjusted EBITDA of $4 million, excluding one-off ERP implementation costs, marking three consecutive quarters of profit from operations.
- Rubicon Organics Inc (ROMJF) successfully launched its Vape products, achieving over 13% national market share and 56% national distribution within six months.
- The company received GACP certification for its Delta facility, enabling its inaugural international shipment to Poland, and expanded its production capacity by acquiring a new facility in Hope, BC.
- Rubicon Organics Inc (ROMJF) maintained a strong balance sheet with a competitive interest rate of 6.75% on its refinanced credit facility, supporting future growth initiatives.
- The first half of 2024 was challenging for Rubicon Organics Inc (ROMJF), with only modest year-over-year net revenue growth due to soft consumer sentiment and price compression.
- Gross profit was negatively impacted by an adverse product mix, price compression, and a shift towards larger flower formats.
- The company experienced a decline in operating cash flow in Q1 2024 due to a slower start in sales, ERP project investment, and working capital needs for the Vape launch.
- Inventory expenses increased from 34% to 43% in 2024 due to price pressure, a trend towards lower margin flower SKUs, and involvement of third-party manufacturers.
- Rubicon Organics Inc (ROMJF) faced capacity constraints in 2024, particularly in larger formats, impacting its ability to meet demand.
Good morning, everyone. Welcome to the conference call for Rubicon Organics Q4 financial results for the 3 and 12 months ended December 31, 2024. As a reminder, this conference call is being recorded on April 2, 2025. (Operator Instructions).
Before we begin, I will refer you to slide 2, of our presentation, which contains Rubicon's caution regarding forward-looking statements and non-GAAP measures. Today's presenters will be Margaret Brody, CEO; and Janis Risbin, CFO.
I will now turn the go to Margaret Brody for the presentation.
Good morning everyone.
Today I'll provide an update on Rubicon Organics and our achievements in 2024 as Canada's leading house of premium cannabis brands. I will also provide some color on our growth opportunities and where we are seeing what we are seeing as a resurgence in Canadian cannabis, as well, our CFO, Janis Risbin will cover our financial highlights.
2024 was a record year for Rubicon Organics, achieving several milestones.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
